Global Man-made Vascular Graft Market Growth 2023-2029
Man-made Vascular Grafts are used to replace, bypass or maintain function of damaged, occluded or diseased blood vessels in small, medium and large diameter.
LPI (LP Information)' newest research report, the “Man-made Vascular Graft Industry Forecast” looks at past sales and reviews total world Man-made Vascular Graft sales in 2022, providing a comprehensive analysis by region and market sector of projected Man-made Vascular Graft sales for 2023 through 2029. With Man-made Vascular Graft sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Man-made Vascular Graft industry.
This Insight Report provides a comprehensive analysis of the global Man-made Vascular Graft landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Man-made Vascular Graft portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Man-made Vascular Graft market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Man-made Vascular Graft and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Man-made Vascular Graft.
The global Man-made Vascular Graft market size is projected to grow from US$ 3542 million in 2022 to US$ 5259.2 million in 2029; it is expected to grow at a CAGR of 5259.2 from 2023 to 2029.
The major players in global Man-made Vascular Graft market include Getinge, Terumo, Bard PV, etc. The top 3 players hold over 65% of global market shares. Asia-Pacific and North America are main markets, they occupy about 70% of the global market. ePTFE Vascular Graft is the main type, with a share over 50%. Cardiovascular diseases and Aneurysm are the key applications, which hold over 60% shares altogether.
This report presents a comprehensive overview, market shares, and growth opportunities of Man-made Vascular Graft market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
ePTFE Man-made Vascular Graft
Polyester Man-made Vascular Graft
PTFE Man-made Vascular Graft
Others
Segmentation by application
Cardiovascular Diseases
Aneurysm
Vascular Occlusion
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Getinge
Bard PV
Terumo
W. L. Gore
Junkne Medical
B.Braun
LeMaitre Vascular
Suokang
Chest Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Man-made Vascular Graft market?
What factors are driving Man-made Vascular Graft market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Man-made Vascular Graft market opportunities vary by end market size?
How does Man-made Vascular Graft break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook